Binaural Beats Embedded in Old Songs: Participants in the intervention group will listen to old songs embedded with 10-Hz alpha-frequency binaural beats through headphones once daily for 30 minutes for 14 consecutive days. The old songs will be selected according to older adults' music preferences.
Old Songs: Participants in the control group will listen to old songs without binaural beats through headphones once daily for 30 minutes for 14 consecutive days. The old songs will be selected according to older adults' music preferences.
Study summary
This study will evaluate whether binaural beats can improve cognitive function in older adults with mild cognitive impairment living in nursing homes. Participants will listen to 10-Hz alpha-frequency binaural beats through headphones once daily for 30 minutes for 14 consecutive days. Cognitive function, sleep quality, anxiety, and depressive symptoms will be assessed before the intervention, after the intervention, and at a 2-week follow-up after the intervention. The study aims to determine whether binaural beats are a safe, simple, and non-drug approach to support cognitive health in older adults with mild cognitive impairment.
Eligibility
Sex
ALL
Min age
60 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. Age 60 years or older.
2. Not previously diagnosed with dementia.
3. Meets the diagnostic criteria for mild cognitive impairment, with Montreal Cognitive Assessment scores adjusted by education level, Mini-Mental State Examination score \>= 24, and Activities of Daily Living score \< 23.
4. Has lived in a nursing home for more than 2 months and plans to continue living there during the study period.
5. No hearing impairment; Hearing Handicap Inventory for the Elderly-Screening Version score \< 8, and able to hear binaural beats through both ears.
6. Conscious and able to cooperate with questionnaires and scale assessments.
7. Has not taken medications that may affect cognitive function within 3 to 6 months before the intervention.
Exclusion Criteria:
1. Severe physical disease, major organ failure, or advanced malignant tumor.
2. Diagnosed depression or other psychiatric disorders.
Withdrawal Criteria:
1. Serious adverse events during the study, such as falls, disease recurrence, discomfort caused by the intervention audio, death, or other conditions making continued participation unsuitable.
2. Voluntary withdrawal from the study.
Removal Criteria:
1. Incomplete data resulting in missing information.
2. Missing three or more intervention sessions within 2 weeks without following intervention instructions.
3. Receiving other treatments or interventions related to cognitive function during the trial.
Primary outcome measure(s)
Change in Montreal Cognitive Assessment Score — Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention Cognitive function will be assessed using the Montreal Cognitive Assessment. The total score ranges from 0 to 30, with higher scores indicating better cognitive function.
Change in Digit Span Test Score — Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
Change in Stroop Color-Word Test Score — Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
Change in Trail Making Test Score — Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
Change in Pittsburgh Sleep Quality Index Score — Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
Change in Geriatric Anxiety Scale Score — Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
Change in Geriatric Depression Scale-15 Score — Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
Trial sites (3)
Facility
City
Region
Status
Jintaiyang Jingguan Elderly Care Apartment
Shenyang
Liaoning
Recruiting
Jintaiyang Elderly Care Center, Huanggu Branch
Shenyang
Liaoning
Recruiting
Renai Changwan Elderly Care Home, Dadong District
Shenyang
Liaoning
Recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.